A stem cell treatment helped improve the motor function of two out of four patients with a spinal cord injury in the first clinical study of its kind, Japanese scientists said. A spinal cord ...

Data were collected using a general information questionnaire, the SPB Scale, and the Caregiver Reaction Assessment (CRA ... Grade D or worse as promulgated by the American Spinal Cord Injury ...

This week, the US Food and Drug Administration (FDA) and China’s National Medical Products Administration (NMPA) approved the global clinical trial to treat spinal cord injury (SCI), which is ...

Individuals with incomplete spinal cord injury safely received a combination of stimulation of a nerve in the neck with progressive, individualized rehabilitation. This approach, called closed ...

[2] Spinal cord compression constitutes a true emergency because the initial injury to the spinal cord will lead to permanent loss of neurologic function if the pressure of the tumor on the cord ...

will be presenting at the prestigious annual meeting of the American Spinal Injury Association ("ASIA”), where he will discuss the Company's plans for future clinical trials in 2026 in the field of ...

Exercise type was customized for each participant based on their ability. Initial exercise selection was based on the GRASSP profile (Fig. 3d) of each participant. Credit: Nature (2025). DOI: 10. ...

As the first regenerative clinical trial globally employing a subtype-specific neural progenitor cell therapeutic product to treat spinal cord injury ... Eli Lilly Asia Ventures, Sequoia Capital ...

Pairing targeted vagus nerve stimulation with physical therapy seems to help people who are partially paralysed from spinal cord injuries regain the ability to perform some everyday activities ...

Tests in 17 people without a spinal cord injury showed that the decoder could cue movement in their lower legs using spinal cord stimulation, researchers reported in the Journal of ...

Intracortical microstimulation of the somatosensory cortex evokes tactile sensations, but those of individual electrodes are insufficient for functional tasks. We show that stimulating multiple ...

NervGen has received Fast Track designation from the FDA for NVG-291 in individuals with spinal cord injury.